无症状重度和中度主动脉狭窄:评估治疗适应症的时间。

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Structural Heart Pub Date : 2023-09-01 DOI:10.1016/j.shj.2023.100201
Marko Banovic MD, PhD , Bernard Iung MD, PhD , Wojtek Wojakowski MD, PhD , Nicholas Van Mieghem MD, PhD , Jozef Bartunek MD, PhD
{"title":"无症状重度和中度主动脉狭窄:评估治疗适应症的时间。","authors":"Marko Banovic MD, PhD ,&nbsp;Bernard Iung MD, PhD ,&nbsp;Wojtek Wojakowski MD, PhD ,&nbsp;Nicholas Van Mieghem MD, PhD ,&nbsp;Jozef Bartunek MD, PhD","doi":"10.1016/j.shj.2023.100201","DOIUrl":null,"url":null,"abstract":"<div><p>Over the last decades, we have witnessed considerable improvements in diagnostics and risk stratification of patients with significant aortic stenosis (AS), paralleled by advances in operative and anesthetic techniques. In addition, accumulating evidence points to the potential benefit of early valve replacement in such patients prior to the onset of symptoms. In parallel, interventional randomized trials have proven the benefit of transcatheter aortic valve replacement in comparison to a surgical approach to valve replacement over a broad risk spectrum in symptomatic patients with AS. This article reviews contemporary management approaches and scrutinizes open questions regarding timing and mode of intervention in asymptomatic patients with severe AS. We also discuss the challenges surrounding the management of symptomatic patients with moderate AS as well as emerging dilemmas related to the concept of a life-long treatment strategy for patients with AS.</p></div>","PeriodicalId":36053,"journal":{"name":"Structural Heart","volume":"7 5","pages":"Article 100201"},"PeriodicalIF":1.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512009/pdf/","citationCount":"0","resultStr":"{\"title\":\"Asymptomatic Severe and Moderate Aortic Stenosis: Time for Appraisal of Treatment Indications\",\"authors\":\"Marko Banovic MD, PhD ,&nbsp;Bernard Iung MD, PhD ,&nbsp;Wojtek Wojakowski MD, PhD ,&nbsp;Nicholas Van Mieghem MD, PhD ,&nbsp;Jozef Bartunek MD, PhD\",\"doi\":\"10.1016/j.shj.2023.100201\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Over the last decades, we have witnessed considerable improvements in diagnostics and risk stratification of patients with significant aortic stenosis (AS), paralleled by advances in operative and anesthetic techniques. In addition, accumulating evidence points to the potential benefit of early valve replacement in such patients prior to the onset of symptoms. In parallel, interventional randomized trials have proven the benefit of transcatheter aortic valve replacement in comparison to a surgical approach to valve replacement over a broad risk spectrum in symptomatic patients with AS. This article reviews contemporary management approaches and scrutinizes open questions regarding timing and mode of intervention in asymptomatic patients with severe AS. We also discuss the challenges surrounding the management of symptomatic patients with moderate AS as well as emerging dilemmas related to the concept of a life-long treatment strategy for patients with AS.</p></div>\",\"PeriodicalId\":36053,\"journal\":{\"name\":\"Structural Heart\",\"volume\":\"7 5\",\"pages\":\"Article 100201\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512009/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Structural Heart\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2474870623000830\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Structural Heart","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2474870623000830","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

在过去的几十年里,我们见证了严重主动脉瓣狭窄(AS)患者的诊断和风险分层的显著改善,同时手术和麻醉技术也取得了进步。此外,越来越多的证据表明,在这些患者出现症状之前,早期瓣膜置换术有潜在的好处。同时,在有症状的AS患者中,介入性随机试验已经证明,与外科瓣膜置换术相比,经导管主动脉瓣置换术在广泛的风险范围内是有益的。本文回顾了当代的管理方法,并仔细研究了关于严重AS无症状患者干预时机和模式的悬而未决的问题。我们还讨论了围绕中度AS症状患者管理的挑战,以及与AS患者终身治疗策略概念相关的新出现的困境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Asymptomatic Severe and Moderate Aortic Stenosis: Time for Appraisal of Treatment Indications

Over the last decades, we have witnessed considerable improvements in diagnostics and risk stratification of patients with significant aortic stenosis (AS), paralleled by advances in operative and anesthetic techniques. In addition, accumulating evidence points to the potential benefit of early valve replacement in such patients prior to the onset of symptoms. In parallel, interventional randomized trials have proven the benefit of transcatheter aortic valve replacement in comparison to a surgical approach to valve replacement over a broad risk spectrum in symptomatic patients with AS. This article reviews contemporary management approaches and scrutinizes open questions regarding timing and mode of intervention in asymptomatic patients with severe AS. We also discuss the challenges surrounding the management of symptomatic patients with moderate AS as well as emerging dilemmas related to the concept of a life-long treatment strategy for patients with AS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Structural Heart
Structural Heart Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.60
自引率
0.00%
发文量
81
期刊最新文献
Moderate Aortic Stenosis—Advanced Imaging, Risk Assessment, and Treatment Strategies The Transcatheter Aortic Valve Replacement-Conduction Study: The Value of the His-Ventricular Interval in Risk Stratification for Post-TAVR Atrioventricular-Block Large Field-of-View Intravascular Ultrasound for Mitral and Tricuspid Valve-in-Valve Guidance: A Pilot Study Quantitative Aortography Analysis of JenaValve’s Trilogy Transcatheter Aortic Valve Implantation System in Patients With Aortic Regurgitation or Stenosis A Novel Risk Score Facilitates Femoral Artery Access in Transcatheter Aortic Valve Implantation: Passage-Puncture Score
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1